Perfusion Augmentation Through Exercise
PERFEX
Changes in PERFusion and Cerebrovascular Reactivity Through Aerobic EXercise Training After Ischemic Stroke - a Proof of Concept Randomized Controlled Trial
1 other identifier
interventional
40
1 country
3
Brief Summary
Large cerebral vessel occlusion is a common phenomenon in the general population and accounts for 13-35% of ischemic strokes. Chronic stenosis in the large cerebral arteries is associated with cerebral hypoperfusion, cognitive decline and an increased risk of stroke or recurrent stroke, respectively. Even with upgrowth of surgical or endovascular interventions, mechanical reopening of the occluded vessels is often not possible. Alternative treatment opportunities include minimal-to-moderate blood pressure elevation (typically by ceasing antihypertensives) waiting for collateral circulation to develop spontaneously. Another conservative approach to increase cerebral perfusion is aerobic exercising. Physical activity has shown to lead to cerebral blood flow increase, especially in activated brain areas of healthy human and rat models. However, it is remains unknown, how physiological adaptation to physical activity expresses in persons after stroke due to large vessel occlusion. Herein, it is hypothesized that aerobic exercise facilitates the development of an extensive and functional vascular collateral network in persons with ischemic stroke and perfusion compromise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2022
CompletedFirst Posted
Study publicly available on registry
October 18, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 18, 2022
October 1, 2022
2.1 years
September 15, 2022
October 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain imaging - cerebrovascular reactivity (CVR) by BOLD-fMRI
Functional brain tissue perfusion and tissue at risk based on cerebrovascular reactivity by blood oxygenation-level dependent functional magnetic resonance imaging (BOLD-fMRI), measured as the percentage BOLD signal change /mmHg CO2.
post-intervention (12 weeks)
Secondary Outcomes (16)
Brain imaging - intravoxel incoherent motion (IVIM)
post-intervention (12 weeks)
Brain imaging - NOVA-qMRI
post-intervention (12 weeks)
Brain imaging - Lesion volume
post-intervention (12 weeks)
Brain imaging - Collateral status
post-intervention (12 weeks)
Exercise stress testing
post-intervention (12 weeks)
- +11 more secondary outcomes
Other Outcomes (1)
Concomitant medications
post-intervention (12 weeks) + follow-up (+3 months)
Study Arms (2)
aerobic treadmill training
EXPERIMENTALProgressive graded, high-intensity aerobic treadmill training is delivered over 36 sessions at a frequency of 3x per week for 30-50 minutes of training per session over a period of 3 months. If possible, the training intensity is progressed from 40% to 80% of heart rate reserve, according to the supervising therapist.
stretching exercise
ACTIVE COMPARATORThe control intervention includes stretching exercise therapy similarly heart rate controlled within limits up to 20% of heart rate reserve over 36 sessions at a frequency of 3x per week for 30 minutes.
Interventions
The intervention will be delivered based on the initial exercise testing and graded based by increasing the duration, speed and/or altitude of the treadmill training.
Interventions, such as stretching, relaxation, passive soft-tissue technics (excl. manipulation) that do not elevate the heart rate above 20HRR
Eligibility Criteria
You may qualify if:
- Male and Female patients of 18 years of age or above
- Subjects after ischemic cerebral stroke (≥ 3 months) due to large vessel occlusion
- Subjects do not qualify for flow augmentation through ECIC bypass or endovascular treatment
- Persistent deficit in BOLD-CVR
- Functional Ambulatory Categories \>2
- Discharged from hospitalization / inpatient rehabilitation
- Living independent before stroke (mRS ≤3)
- Written Informed Consent
You may not qualify if:
- Severe cardiac disease, such as instable angina pectoris, pericarditis, heart failure (New York Health Association \> II°), or hemodynamically significant valvular dysfunction
- Complete arterial stenosis
- Peripheral artery disease with mild to moderate claudication at \< 200m or 200-1000m of walking
- Contra-indication, such as a history of a seizure, prior electroconvulsive therapy, deep brain stimulators or other metal in the head, skull defect, pacemaker, neuroleptic medication
- Inability to follow the procedures of the study, e.g., due to language problems (unable to follow to stage commands), psychological disorders (major depression), and / or a neurodegenerative disease (dementia)
- Known or suspected non-compliance, documented drug, or alcohol abuse
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Ambulante Reha Triemli Zürich
Zurich, Switzerland
Klinik Lengg AG
Zurich, Switzerland
University Hospital Zurich
Zurich, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Globas, MD
University Hospital and University of Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2022
First Posted
October 18, 2022
Study Start
November 1, 2022
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
October 18, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share